(Q61975950)
Statements
GMX07 (English)
0 references
A Phase III, Multicenter, Open-label, Randomized, Two-Period, Crossover Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases (English)
0 references
February 2014
0 references
January 2016
0 references
48
0 references
2 year
0 references
55 year
0 references